PARNATE®

PrPARNATE®
Tranylcypromine Tablets USP
CONSUMER INFORMATION
This leaflet is part III of a three-part “Product Monograph” published for PARNATE®, approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not …

Number of Children & Adolescents Taking Psychiatric Drugs in the U.S.

Number of Children & Adolescents Taking Psychiatric Drugs in the U.S.
The following information is the most accurate and documented data available on psychiatric drug usage in the United States. The information is from IMS Health, …

Depakote Tablets

Depakote Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Depakote® 250mg and 500mg Tablets
Valproic acid (as valproate semisodium)
Is this leaflet hard to see or read?
Phone 0845 372 7101 for help
▼ This medicine is subject to additional monitoring. This …

VISTARIL® (Hydroxyzine Pamoate)

VISTARIL® (Hydroxyzine Pamoate)
Capsules and Oral Suspension
DESCRIPTION
Hydroxyzine pamoate is designated chemically as 1-(p-chlorobenzhydryl) 4- [2-(2-hydroxyethoxy) ethyl] diethylenediamine salt of 1,1′-methylene bis (2 hydroxy- 3-naphthalene carboxylic acid).
Inert ingredients for the capsule formulations are: hard gelatin capsules …

Selected Facts about Mental Health in the United States

Selected Facts about Mental Health in the United States
Overview

An estimated 61.5 million Americans—about one in four adults—suffer from a diagnosable mental disorder in a given year. About 13.6 million Americans, or 1 in 17, suffer …